Cargando…

Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy

Non-small cell lung cancer (NSCLC) is a heterogeneous disease with genetic and environmental parameters that influence cell metabolism. Because of the complex interplay of environmental factors within the tumor microenvironment (TME) and the profound impact of these factors on the metabolic activiti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Shuxiao, Suman, Shankar, Amann, Joseph M., Wu, Ruohan, Carbone, David P., Wang, Jie, Dikov, Mikhail M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344351/ https://www.ncbi.nlm.nih.gov/pubmed/35914370 http://dx.doi.org/10.1016/j.neo.2022.100824

Ejemplares similares

Improving combination therapies: targeting A(2B)-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression
por: Evans, Jason V, et al.
Publicado: (2023)

Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer
por: Zhulai, Galina, et al.
Publicado: (2022)

miR‐21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy
por: Usuelli, Vera, et al.
Publicado: (2021)

Genetic Modifiers of Chromatin Acetylation Antagonize the Reprogramming of Epi-Polymorphisms
por: Abraham, Anne-Laure, et al.
Publicado: (2012)

Metabolic Reprogramming in Modulating T Cell Reactive Oxygen Species Generation and Antioxidant Capacity
por: Rashida Gnanaprakasam, Josephin N., et al.
Publicado: (2018)

Metabolic Reprogramming, Questioning, and Implications for Cancer
por: Jacquet, Pierre, et al.
Publicado: (2021)

Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors
por: Slaats, Jeroen, et al.
Publicado: (2022)

Functional Reprogramming of the Primary Immune Response by T Cell Receptor Antagonism
por: Haribhai, Dipica, et al.
Publicado: (2004)

Accumulation of endogenous adenosine improves cardiomyocyte metabolism via epigenetic reprogramming in an ischemia-reperfusion model
por: Wang, Peng, et al.
Publicado: (2023)

Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
por: Gandhi, Nishant, et al.
Publicado: (2019)

Methylthioadenosine Reprograms Macrophage Activation through Adenosine Receptor Stimulation
por: Keyel, Peter A., et al.
Publicado: (2014)

Bortezomib enhances anti-tumor T cell immunity by remodeling Notch system
por: Thounaojam, Menaka, et al.
Publicado: (2014)

Erythrocyte adenosine A2B receptor prevents cognitive and auditory dysfunction by promoting hypoxic and metabolic reprogramming
por: Qiang, Qingfen, et al.
Publicado: (2021)

ANTAGONISM BY DIBUTYRYL ADENOSINE CYCLIC 3',5'-MONOPHOSPHATE AND TESTOSTERONE OF CELL ROUNDING REACTIONS
por: Storrie, Brian
Publicado: (1973)

Antagonism by dibutyryl adenosine cyclic 3',5'-monophosphate and testololactone of concanavalin A capping
Publicado: (1975)

The RNA binding domain of Pumilio antagonizes poly-adenosine binding protein and accelerates deadenylation
por: Weidmann, Chase A., et al.
Publicado: (2014)

Allosteric Antagonism of the A(2A) Adenosine Receptor by a Series of Bitopic Ligands
por: Gao, Zhan-Guo, et al.
Publicado: (2020)

Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings
por: Goruganthu, Mounika U. L., et al.
Publicado: (2020)

The H3.3K27M oncohistone antagonizes reprogramming in Drosophila
por: Ahmad, Kami, et al.
Publicado: (2021)

Photoreceptor metabolic reprogramming: current understanding and therapeutic implications
por: Pan, Warren W., et al.
Publicado: (2021)

Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis
por: Ma, Ying, et al.
Publicado: (2021)

The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway
por: Ling, Song, et al.
Publicado: (2007)

Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
por: Zhao, Jiangang, et al.
Publicado: (2020)

Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
por: Nenkov, Miljana, et al.
Publicado: (2021)

Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma
por: Marabitti, Veronica, et al.
Publicado: (2022)

Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy
por: Qiao, Xuehan, et al.
Publicado: (2023)

Mitogen-stimulated glucose transport in thymocytes. Possible role of Ca++ and antagonism by adenosine 3':5'-monophosphate
Publicado: (1977)

Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes
por: Sellers, Katherine, et al.
Publicado: (2019)

Metabolic Reprogramming of Host Cells in Response to Enteroviral Infection
por: Cheng, Mei-Ling, et al.
Publicado: (2020)

A(2A) Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction
por: Hurtado-Alvarado, Gabriela, et al.
Publicado: (2016)

Antagonism in olfactory receptor neurons and its implications for the perception of odor mixtures
por: Reddy, Gautam, et al.
Publicado: (2018)

Cancer therapy by resuscitating Notch immune surveillance
por: Shanker, Anil, et al.
Publicado: (2014)

Adenosine, Energy Metabolism, and Sleep
por: Porkka-Heiskanen, Tarja, et al.
Publicado: (2003)

Epigenetic reprogramming in small cell lung cancer
por: Chen, Jingyao, et al.
Publicado: (2022)

Increasing Notch signaling antagonizes PRC2-mediated silencing to promote reprograming of germ cells into neurons
por: Seelk, Stefanie, et al.
Publicado: (2016)

Cancer therapy by restoration of immune Notch
por: Shanker, Anil, et al.
Publicado: (2013)

Tumor metabolic reprogramming in lung cancer progression
por: Li, Xin, et al.
Publicado: (2022)

Metabolic Reprogramming of Liver Fibrosis
por: Delgado, M. Eugenia, et al.
Publicado: (2021)

Metabolic reprogramming through mitochondrial biogenesis drives adenosine anti-inflammatory effects: new mechanism controlling gingival fibroblast hyper-inflammatory state
por: Paladines, Nathalie, et al.
Publicado: (2023)

STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
por: Poli, Valeria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qi98s3514r20lsg5n25q3ks4s6